24 May 2013
Keywords: Alfa Wassermann, Norgine, Targaxan, Xifaxan, UK launch, Hepatic encephalopathy, Liver disease
Article | 28 January 2013
Following recent European Union approval (The Pharma Letter December 9, 2012), Netherlands-based Norgine Pharmaceuticals and Italy’s Alfa Wassermann have announced ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.